Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Merck Acquires Microbiology Business
by Marc S. Reisch
March 28, 2011
| A version of this story appeared in
Volume 89, Issue 13
Germany’s Merck has acquired the microbiology testing business of Dreieich, Germany-based Biotest. The business had 2010 sales of $67 million and has about 290 employees. Merck says the acquisition will be used to strengthen the industrial biomonitoring business of its EMD Millipore unit. Merck acquired U.S.-based Millipore in a $7.2 billion deal last year. Biotest’s ready-to-use media and its particle-counting and air-monitoring equipment are primarily used in the pharmaceutical, food, and personal care industries.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter